Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Closing rural diagnostic gap, HealthTrackRx delivers next-morning PCR test results nationwide to improve infection diagnosis and treatment.

Co-Dx will equip the JV with an exclusive licence to utilise, produce, and market the licensed intellectual property.

Roche has obtained CE mark approval for its fully automated immunoassay, Elecsys Dengue Ag test, intended for diagnosing ...

The hospital system is betting the move will give it better control over turnaround time and allow it to be more "nimble" in ...

In a fast-changing world that is learning to live with climate change, industrial farming and evolving ecosystems, food safety has become a critical concern for both producers and consumers. Seqlo by ...

Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...

The Global Sepsis Diagnostics Market size, valued at USD 1,133.2 million in 2018, grew substantially to USD 1,790.9 million ...

New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute ...

The high-throughput antigen test includes all four dengue virus serotypes and returns results in about 18 minutes.

NEW YORK – Danaher subsidiary Cepheid announced on Tuesday that its Xpert MTB/XDR test for tuberculosis drug resistance has been awarded prequalification status by the World Health Organization.

Among over 800 children exposed to maternal SARS-CoV-2 infection during pregnancy, 16.3% had a neurodevelopmental diagnosis ...